Cargando…
Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa
Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology’s latest editorial board member Ghassan Abou-Alfa.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137175/ https://www.ncbi.nlm.nih.gov/pubmed/32273973 http://dx.doi.org/10.2217/hep-2020-0008 |